Early-onset levodopa responsive parkinsonism in PPP2R5D mutation

Parkinsonism Relat Disord. 2024 Jun:123:106952. doi: 10.1016/j.parkreldis.2024.106952. Epub 2024 Apr 4.

Authors

Rohan Mahale¹, Gautham Arunachal², Deepak Chadha³, Hansashree Padmanabha³, Pooja M³, Mathuranath Pavagada³

Affiliations

¹ Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, 560029, India. Electronic address: [email protected].
² Department of Human Genetics, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, 560029, India.
³ Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, 560029, India.

PMID: 38582018
DOI: 10.1016/j.parkreldis.2024.106952

No abstract available

Keywords: Early-onset parkinsonism; Levodopa; PPP2R5D.

Publication types

Letter
Case Reports

MeSH terms

Adult
Antiparkinson Agents / therapeutic use
Female
Humans
Levodopa*
Male
Mutation*
Parkinsonian Disorders* / drug therapy
Parkinsonian Disorders* / genetics
Phosphoric Monoester Hydrolases
Protein Phosphatase 2* / genetics

Substances

Levodopa
Protein Phosphatase 2
phosphoinositide 5-phosphatase
Antiparkinson Agents
Phosphoric Monoester Hydrolases